Stocks and Investing
Stocks and Investing
Fri, February 3, 2023
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
[ Fri, Feb 03rd 2023
] - WOPRAI
Vernon Bernardino Reiterated (ARTL) at Strong Buy and Held Target at $55 on, Feb 3rd, 2023
Vernon Bernardino of HC Wainwright & Co., Reiterated "Artelo Biosciences, Inc." (ARTL) at Strong Buy and Held Target at $55 on, Feb 3rd, 2023.
Vernon, nor any peers, have made any analyst calls on ARTL in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources